Skip to main content
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
- Bowtell, David D;
- Böhm, Steffen;
- Ahmed, Ahmed A;
- Aspuria, Paul-Joseph;
- Bast, Robert C;
- Beral, Valerie;
- Berek, Jonathan S;
- Birrer, Michael J;
- Blagden, Sarah;
- Bookman, Michael A;
- Brenton, James D;
- Chiappinelli, Katherine B;
- Martins, Filipe Correia;
- Coukos, George;
- Drapkin, Ronny;
- Edmondson, Richard;
- Fotopoulou, Christina;
- Gabra, Hani;
- Galon, Jérôme;
- Gourley, Charlie;
- Heong, Valerie;
- Huntsman, David G;
- Iwanicki, Marcin;
- Karlan, Beth Y;
- Kaye, Allyson;
- Lengyel, Ernst;
- Levine, Douglas A;
- Lu, Karen H;
- McNeish, Iain A;
- Menon, Usha;
- Narod, Steven A;
- Nelson, Brad H;
- Nephew, Kenneth P;
- Pharoah, Paul;
- Powell, Daniel J;
- Ramos, Pilar;
- Romero, Iris L;
- Scott, Clare L;
- Sood, Anil K;
- Stronach, Euan A;
- Balkwill, Frances R
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892184/pdf/nihms787460.pdfNo data is associated with this publication.
Abstract
This Opinion article outlines a set of research priorities, based on discussions held at the 2015 Helene Harris Memorial Trust Ovarian Cancer Action meeting, that the authors believe will reduce incidence and improve outcomes for women with high-grade serous ovarian cancer.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.